Your browser doesn't support javascript.
loading
Effects of Somatostatin Analogue Pretreatment on Ovarian Response to Ovulation Induction in Patients with Polycystic Ovarian Syndrome / 대한산부인과학회잡지
Korean Journal of Obstetrics and Gynecology ; : 423-430, 2000.
Artigo em Coreano | WPRIM | ID: wpr-181720
ABSTRACT

OBJECTIVE:

To determine whether the somatostain analogue, octreotide, pretreatment before ovulation induction with human menopausal gonadotropin (hMG) affects ovarian response, and ovulation induction outcome in infertile patients with polycystic ovarian syndrome (PCOS) resistant to clomiphene citrate (CC)

METHODS:

From November 1998 to June 1999, 30 infertile patients with PCOS unresponsive to CC were randomly allocated either octreotide pretreatment (treatment group) (n = 15) or hMG alone (control group) (n = 15) groups. In the treatment group, 100 g of octreotide were administered daily for 7 days after progesterone injection for withdrawal bleeding, and then hMG was administered for ovulation induction.

RESULTS:

There were no differences in the total number of hMG ampules required and the duration of hMG administration between the two groups. The number of follicles of 10-14 mm diameter on the day of hCG injection was significantly less in the treatment group than that in the control group (4.3 +/- 2.5 vs. 9.6 +/- 4.4, p < 0.001). The serum estradiol (E2) level on the day of hCG injection was significantly lower in the treatment group, with 1579.2 +/- 421.0 pg/ml compared with 2120.3 +/- 512.7 pg/ml in the control group (p < 0.001). The hematocrit level on the day of hCG injection was also significantly lower in the treatment group than that in the control group (36.9 +/- 2.1% vs. 40.8 +/- 2.9%, p < 0.05). The incidence of severe ovarian hyperstimulation syndrome (OHSS) seemed to be lower in the treatment group, but the difference did not achieve significance (6.7% vs 20.0%).

CONCLUSION:

This study suggests that octreotide pretreatment before ovulation induction could improve hormonal milieu compared to hMG alone, and therefore may be effective in ovulation induction for patients with PCOS resistant to CC.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Ovulação / Indução da Ovulação / Síndrome do Ovário Policístico / Progesterona / Somatostatina / Octreotida / Incidência / Síndrome de Hiperestimulação Ovariana / Clomifeno / Estradiol Tipo de estudo: Estudo de incidência / Estudo prognóstico Limite: Feminino / Humanos Idioma: Coreano Revista: Korean Journal of Obstetrics and Gynecology Ano de publicação: 2000 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Ovulação / Indução da Ovulação / Síndrome do Ovário Policístico / Progesterona / Somatostatina / Octreotida / Incidência / Síndrome de Hiperestimulação Ovariana / Clomifeno / Estradiol Tipo de estudo: Estudo de incidência / Estudo prognóstico Limite: Feminino / Humanos Idioma: Coreano Revista: Korean Journal of Obstetrics and Gynecology Ano de publicação: 2000 Tipo de documento: Artigo